Cargando…

Carrier-Free Gambogic Acid Dimer Self-Assembly Nanomedicines for Rheumatoid Arthritis Treatment

INTRODUCTION: The insufficient targeting delivery of therapeutic agents greatly impeded the treatment outcomes of rheumatoid arthritis (RA). Despite the recognized therapeutic advantages of gambogic acid (GBA) in inflammatory diseases, its high delivery efficiency to inflammatory site still limits i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yuling, Nie, Xin, Wu, Yihan, Lin, Longfei, Liao, Qian, Li, Jingjing, Lee, Simon Ming-Yuen, Li, Hui, Zhang, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522496/ https://www.ncbi.nlm.nih.gov/pubmed/37771407 http://dx.doi.org/10.2147/IJN.S422096

Ejemplares similares

Gambogic Acid as a Candidate for Cancer Therapy: A Review
por: Liu, Yuling, et al.
Publicado: (2020)

Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer
por: Kebebe, Dereje, et al.
Publicado: (2019)

Carrier-free nanomedicines self-assembled from palbociclib dimers and Ce6 for enhanced combined chemo-photodynamic therapy of breast cancer
por: Huang, Zheng, et al.
Publicado: (2023)

Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment
por: Huang, Rui, et al.
Publicado: (2018)

A Gamboge Case
por: Biegler, J. A.
Publicado: (1887)

Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy
por: Huang, Xiuyu, et al.
Publicado: (2022)

Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
por: Barnes, Theresa, et al.
Publicado: (2007)

Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies
por: Wang, Qin, et al.
Publicado: (2021)

Evaluation of Ruthenium-Based Assemblies as Carriers of Photosensitizers to Treat Rheumatoid Arthritis by Photodynamic Therapy
por: Gallardo-Villagrán, Manuel, et al.
Publicado: (2021)

Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy
por: Zou, Liang, et al.
Publicado: (2021)

Polymeric Carriers for Biomedical and Nanomedicine Application
por: Lima, Sofia A. Costa, et al.
Publicado: (2021)

Structural Optimization and Improving Antitumor Potential of Moreollic Acid from Gamboge
por: Cheng, Li-Zhi, et al.
Publicado: (2022)

A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic
por: Zhong, Ting, et al.
Publicado: (2016)

Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
por: Chen, Tao, et al.
Publicado: (2012)

Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2017)

Plasma fibrinogen, d-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis
por: Xue, Li, et al.
Publicado: (2021)

Potent Anti-Inflammatory and Antiproliferative Effects of Gambogic Acid in a Rat Model of Antigen-Induced Arthritis
por: Cascão, Rita, et al.
Publicado: (2014)

Targeting Lymph Nodes for Systemic Immunosuppression Using Cell‐Free‐DNA‐Scavenging And cGAS‐Inhibiting Nanomedicine‐In‐Hydrogel for Rheumatoid Arthritis Immunotherapy
por: Cheng, Furong, et al.
Publicado: (2023)

Deagglomeration of DNA nanomedicine carriers using controlled ultrasonication
por: Hinchliffe, Beth A., et al.
Publicado: (2022)

ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer
por: Ma, Jiachi, et al.
Publicado: (2021)

Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs
por: Li, Meng, et al.
Publicado: (2022)

Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid
por: Li, Mingzhu, et al.
Publicado: (2022)

Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ
por: Du, Yimeng, et al.
Publicado: (2021)

Magnetic and Golden Yogurts. Food as a Potential Nanomedicine Carrier
por: Garcés, Víctor, et al.
Publicado: (2020)

Gambogic acid suppresses colon cancer cell activity in vitro
por: Zhou, Zailong, et al.
Publicado: (2019)

Cell-Free DNA in Rheumatoid Arthritis
por: Hashimoto, Teppei, et al.
Publicado: (2021)

Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin
por: Han, Yiqun, et al.
Publicado: (2014)

Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid
por: Yao, Jing, et al.
Publicado: (2014)

Adaptive Polymeric Assemblies for Applications in Biomimicry and Nanomedicine
por: Altay, Yigit, et al.
Publicado: (2019)

Supramolecular Nanomedicines of In-Situ Self-Assembling Peptides
por: Zhang, Ying, et al.
Publicado: (2022)

Carrier-Free Binary Self-Assembled Nanomedicines Originated from Traditional Herb Medicine with Multifunction to Accelerate MRSA-Infected Wound Healing by Antibacterial, Anti-Inflammation and Promoting Angiogenesis
por: Lu, Jihui, et al.
Publicado: (2023)

Carbon Nanotubes—Potent Carriers for Targeted Drug Delivery in Rheumatoid Arthritis
por: Kofoed Andersen, Camilla, et al.
Publicado: (2021)

Solute carrier nutrient transporters in rheumatoid arthritis fibroblast-like synoviocytes
por: Torres, Alyssa, et al.
Publicado: (2022)

Xanthomatosis in bilateral hands mimicking rheumatoid arthritis: A case report
por: Li, Dan, et al.
Publicado: (2017)

Nuclear Targeted Peptide Combined With Gambogic Acid for Synergistic Treatment of Breast Cancer
por: Dang, Wenli, et al.
Publicado: (2022)

Gambogic Acid and Its Analogs Inhibit Gap Junctional Intercellular Communication
por: Choi, Eun J., et al.
Publicado: (2018)

Gambogic acid and juglone inhibit RNase P through distinct mechanisms
por: Wu Meyers, Nancy, et al.
Publicado: (2022)

Injectable Gamboge-Based In Situ Gel for Sustained Delivery of Imatinib Mesylate
por: Jitrangsri, Kritamorn, et al.
Publicado: (2023)

Gambogic Acid Inhibits Gastric Cancer Cell Proliferation through Necroptosis
por: Wang, Shujun, et al.
Publicado: (2023)

Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer
por: Wang, Shengpeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_itec5b067fb7bak38b3ijjv4g3